A carbapenem-based fluorescence assay for the screening of metallo-β-lactamase inhibitors

A carbapenem-based fluorescence assay for the screening of metallo-β-lactamase inhibitors Assay Platform for Clinically Relevant Metallo-β-lactamases The identification of new metallo-β-lactamase inhibitor leads from fragment-based screening Competitive Inhibitors of the CphA Metallo-β-Lactamase from Aeromonas hydrophila Azolylthioacetamide: A Highly Promising Scaffold for the Development of Metallo-β-lactamase Inhibitors N-Aryl Mercaptopropionamides as Broad-Spectrum Inhibitors of Metallo-β-Lactamases Approved Drugs Containing Thiols as Inhibitors of Metallo-β-lactamases: Strategy To Combat Multidrug-Resistant Bacteria In Vitro Potentiation of Carbapenems with ME1071, a Novel Metallo-β-Lactamase Inhibitor, against Metallo-β-Lactamase- Producing Pseudomonas aeruginosa Clinical Isolates Discovery of Novel Inhibitor Scaffolds against the Metallo-β-lactamase VIM-2 by Surface Plasmon Resonance (SPR) Based Fragment Screening Dipyridyl-substituted thiosemicarbazone as a potent broad-spectrum inhibitor of metallo-β-lactamases